Simulations Plus, Inc. (NASDAQ:SLP) Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC lowered its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 10.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 400,611 shares of the technology company's stock after selling 48,007 shares during the quarter. Geode Capital Management LLC owned about 1.99% of Simulations Plus worth $11,176,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. JPMorgan Chase & Co. grew its holdings in shares of Simulations Plus by 210.7% during the fourth quarter. JPMorgan Chase & Co. now owns 147,154 shares of the technology company's stock worth $4,104,000 after buying an additional 99,789 shares during the last quarter. Summitry LLC acquired a new position in Simulations Plus during the 4th quarter worth approximately $2,385,000. LPL Financial LLC acquired a new position in Simulations Plus during the 4th quarter worth approximately $230,000. KLP Kapitalforvaltning AS acquired a new stake in shares of Simulations Plus in the 4th quarter valued at approximately $86,000. Finally, Sei Investments Co. purchased a new stake in shares of Simulations Plus in the fourth quarter valued at approximately $330,000. Hedge funds and other institutional investors own 78.08% of the company's stock.

Simulations Plus Stock Performance

Simulations Plus stock traded down $0.29 during midday trading on Monday, reaching $35.21. 251,809 shares of the company were exchanged, compared to its average volume of 199,721. The company has a market capitalization of $708.11 million, a price-to-earnings ratio of 88.03 and a beta of 1.13. The firm's 50-day simple moving average is $28.42 and its 200-day simple moving average is $30.29. Simulations Plus, Inc. has a 1 year low of $23.01 and a 1 year high of $51.22.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. The firm had revenue of $22.43 million during the quarter, compared to analysts' expectations of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The firm's quarterly revenue was up 22.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.20 EPS. On average, analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $33.91, for a total value of $678,200.00. Following the sale, the director now directly owns 3,402,584 shares of the company's stock, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 19.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. StockNews.com upgraded Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday. William Blair reiterated an "outperform" rating on shares of Simulations Plus in a research report on Wednesday, January 8th. Finally, KeyCorp increased their price objective on Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 16th. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Simulations Plus presently has a consensus rating of "Moderate Buy" and an average price target of $50.00.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.